Impact of genomic profiling on the treatment and outcomes of patients with advanced gastrointestinal malignancies

The impact of genomic profiling on the outcomes of patients with advanced gastrointestinal (GI) malignancies remains unknown. The primary objectives of the study were to investigate the clinical benefit of genomic‐guided therapy, defined as complete response (CR), partial response (PR), or stable di...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhir, Mashaal, Choudry, Haroon A., Holtzman, Matthew P., Pingpank, James F., Ahrendt, Steven A., Zureikat, Amer H., Hogg, Melissa E., Bartlett, David L., Zeh, Herbert J., Singhi, Aatur D., Bahary, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269696/
https://www.ncbi.nlm.nih.gov/pubmed/28028924
http://dx.doi.org/10.1002/cam4.992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269696/
https://www.ncbi.nlm.nih.gov/pubmed/28028924
http://dx.doi.org/10.1002/cam4.992

Ejemplares similares